BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 25, 2011
View Archived Issues
Ajinomoto synthesizes novel IL-12 and/or IL-23 production inhibitors
Read More
First two stages complete in phase IIb INO-8875 trial in glaucoma
Read More
PET tracer [18F]-SNUBH-NM-333 shows promise in diagnosis of Alzheimer's disease
Read More
GlaxoSmithKline histamine H3 receptor antagonist shows moderate activity in Alzheimer's disease
Read More
New prostanoid EP2 receptor agonists reported by Japanese company
Read More
Celgene discloses novel inhibitors of TNF-alpha production and/or phosphodiesterase 4
Read More
Novel agents for schizophrenia disclosed by Takeda
Read More
Mochida Pharmaceutical prepares new free fatty acid FFA1 receptor agonists
Read More
Sanofi researchers describe new tryptase beta inhibitor prodrugs
Read More
Potent PTP-1B-targeted antisense therapy enters phase I trial in type 2 diabetes
Read More
Enrollment begins in pilot study of Repligen's RG-1068 to improve detection of pancreatic cancer
Read More
EMA's CHMP recommends approval of dexdor
Read More
Takeda discloses preclinical data on new small-molecule GSK-3 inhibitor for Alzheimer's disease
Read More
ACS-84 evaluated in rat model of Parkinson's disease
Read More
Phase I safety data on SAM-760 in healthy young and elderly subjects
Read More
Acacia Pharma initiates phase II study of locally administered xerostomia drug
Read More
Positive CHMP opinion for Incivo
Read More
Janssen Biotech receives FDA complete response letter regarding Simponi
Read More
Biotie Therapies begins phase I imaging trial of SYN-120
Read More
CHMP makes recommendations following review of pioglitazone-containing medicines
Read More
Tarceva recommended for E.U. approval as first-line therapy in distinct type of lung cancer
Read More
FDA committee recommends new approval for Remicade
Read More
Afinitor recommended for new European approval
Read More
CHMP issues opinion on Zytiga in prostate cancer
Read More
R-Tech Ueno amends protocol of its phase I trial in eyelash hypotrichosis
Read More
